New diabetes clinical trial: A Multicenter, Randomized, Double-blind Study of REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis

Published on: May 01, 2025 at 11:00PM
Conditions: Diabetic Ketoacidosis
Interventions: Drug: Reamberin; Drug: Placebo
Sponsors: POLYSAN Scientific & Technological Pharmaceutical Company
Not yet recruiting
https://ift.tt/KhIJ4Yy